Randomized controlled trials have previously addressed the efficacy of mandibular advancement devices (MADs) in the treatment of obstructive sleep apnoea (OSA). The control used in these studies is usually nasal continuous positive airway pressure (nCPAP). It is frequently found to be superior to MAD therapy. In most of these studies nCPAP was titrated objectively but [read the full story…]